Soquel Schafer, PA
Adult Medicine · San Luis Obispo, CANPI 1215442991
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,954 of the $2,843 with a category attached, or 68.7%. 23 manufacturers reported payments, led by Medtronic at 36.9% of the total. 2025 is the largest year on record at $2,208, more than ten times the $14 reported in 2022.
Across 78 payments — averaging $36.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Dendreon Pharmaceuticals LLC$274
- Ferring Pharmaceuticals Inc.$212
- Bayer$179
- Sumitomo Pharma America, Inc.$159
- Antares Pharma, Inc.$139
- plus $831 from 17 others
What the payments were for
- Travel & lodging$76327%
- Food & beverage$1,95469%
- Education$1254%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 14 | $1,048 |
| Dendreon Pharmaceuticals LLC | 4 | $274 |
| Ferring Pharmaceuticals Inc. | 9 | $212 |
| Bayer | 5 | $179 |
| Sumitomo Pharma America, Inc. | 7 | $159 |
| Antares Pharma, Inc. | 12 | $139 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $123 |
| Pfizer | 2 | $111 |
| Novartis | 3 | $89 |
| Endo USA, Inc. | 3 | $75 |
| Progenics Pharmaceuticals, Inc. | 3 | $71 |
| Boston Scientific | 2 | $64 |
| Johnson & Johnson | 2 | $47 |
| Verity Pharmaceuticals Inc. | 2 | $42 |
| Teleflex LLC | 1 | $33 |
| Urogen Pharma, Inc. | 1 | $29 |
| Astellas Pharma US Inc | 1 | $26 |
| Merck | 1 | $25 |
| Blue Earth Diagnostics | 1 | $24 |
| Accord Healthcare, Inc. | 1 | $21 |
| Angiodynamics, Inc. | 1 | $19 |
| Bioprotect Medical, Inc. | 1 | $16 |
| Sun Pharmaceutical Industries Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,843 in reported general payments places this provider in the 85th percentile of 221 adult medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 63 | $667 |
| Finasteride | 58 | $560 |
| Levothyroxine Sodium | 21 | $268 |
| Oxybutynin Chloride ErOxybutynin Chloride | 11 | $106 |
| Losartan Potassium | 14 | $89 |
| Atorvastatin Calcium | 16 | $54 |
Paid to pharmacies, not to this prescriber.
Other adult medicine in San Luis Obispo
- Adam BlankSan Luis Obispo$3K
- Susan HutchinsonLaguna Hills$1M
- Natalia GuzmanLos Angeles$583K
- Richard FauselRancho Mirage$30K
- Benedicto EstoestaValley Springs$22K
- Antoine DipsiaW. Sacramento$21K
- Patrick WelchArroyo Grande$20K
- Craig BobsonManteca$19K
- Tin WongLos Angeles$18K
- Sofia VaismanWoodland Hills$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.